NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Investing
Tilray (NASDAQ:TLRY) Stock Has an Enormous P/B Ratio Right Now
Investing
The Top 3 Cannabis Stocks to Watch in October

Investing
Why Is This Cannabis Fund Manager Sounding the Alarm on Pot Stocks?

Investing
Tilray (NASDAQ:TLRY) Stock Can’t Beat This Marijuana Big Boy on Book Value

Investing
Has the Tilray Inc. (NASDAQ:TLRY) Bubble Burst?

Investing
Marijuana Stocks: Is Tilray Inc.’s (NASDAQ:TLRY) Wild Swings a Sign of Bubble Burst?

Investing
What Are the Risks and Rewards of Investing in Cannabis Stocks?

Investing
Is Tilray Inc. (NASDAQ:TLRY) Really Worth More Than Canopy Growth Corp. (TSX:WEED)?

Investing
Tilray Inc’s (NASDAQ:TLRY) Epic 755% Rally
Investing
This Insane Figure From Aphria Inc. (TSX:APH) Supports Tilray Inc.’s (NASDAQ:TLRY) Valuation but Threatens the Entire Cannabis Industry
